Prognostic estimator of survival for patients with localized and extended pancreatic ductal adenocarcinoma

Cancer Informatics

Volumn 12, Issue , 2013, Pages 103-114

  Gleason, Michael X ^a   Mdzinarishvili, Tengiz ^a   Are, Chandrakanth ^b   Sasson, Aaron ^b   Sherman, Alexander ^a   Shats, Oleg ^a,c   Sherman, Simon ^a,c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c Progenomix Inc   (United States)

Author keywords

Cancer; Cox model; Pancreatic cancer; SEER; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MATHEMATICAL MODEL; PANCREAS ADENOCARCINOMA; RACE; TUMOR VOLUME;

EID: 84875299742     PISSN: None     EISSN: 11769351     Source Type: Journal    
DOI: 10.4137/CIN.S11384     Document Type: Article

References (25)

1. American Cancer Society. Cancer Facts and Figures 2012. Atlanta: American Cancer Society; 2012.
2. Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-JD, editors. SEER Survival Monograph: Cancer Survival Among Adults: US SEER Program, 1988-2001, Patient and Tumor Characteristics. Bethesda, MD: National Cancer Institute; 2007.
3. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA-Cancer J Clin. 2005;55(1):10-30.
4. Warshaw AL, Fernández-del Castillo C. Pancreatic Carcinoma. N Engl J Med. 1992;326(7):455-65.
5. Cubilla AL, Fitzgerald PJ. Tumors of the exocrine pancreas. Washington, DC: Armed Forces Institute of Pathology; 1984.
6. Fesinmeyer MD, Austin MA, Li CI, De Roos AJ, Bowen DJ. Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2005;14(7):1766-73.
7. Bilimoria KY, Bentrem DJ, Ko CY, et al. Validation of the 6th edition AJCC pancreatic cancer staging system. Cancer. 2007;110(4):738-44.
8. Baine M, Sahak F, Lin C, Chakraborty S, Lyden E, Batra SK. Marital Status and Survival in Pancreatic Cancer Patients: A SEER Based Analysis. PLoS ONE. 2011;6(6):e21052.
9. Katz MHG, Hu CY, Fleming JB, Pisters PWT, Lee JE, Chang GJ. Clinical Calculator of Conditional Survival Estimates for Resected and Unresected Survivors of Pancreatic Cancer. Arch Surg. 2012;147(6):513-9.
10. Brennan MF, Kattan MW, Klimstra D, Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004;240(2):293-8.
11. Are C, Afuh C, Ravipati L, Sasson A, Ullrich F, Smith L. Preoperative nomogram to predict risk of perioperative mortality following pancreatic resections for malignancy. J Gastrointest Surg. 2009;13(12):2152-62.
12. Sener S. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg. 1999;189(1):1-7.
13. Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet. 2004; 363(9414):1049-57.
14. Henson DE, Ries LAG. On the estimation of survival. In: Seminars in Surgical Oncology. Wiley Online Library; 2006;10:2-6.
15. Altman DG, Royston P. What do we mean by validating a prognostic model? Statist Med. 2000;19(4):453-73.
16. Surveillance, Epidemiology, and End Results (SEER) Program (http://www. seer.cancer.gov) Limited-Use Data (1973-2009). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2012.
17. Kleinbaum D, Klein M. Survival Analysis: A Self-Learning Text. New York, NY: Springer; 2005.
18. Klein J, Moeschberger M. Survival Analysis: Techniques for Censored and Truncated Data, 2nd ed. New York: Springer; 2003.
19. Weisstein EW. Error Propagation. MathWorld-A Wolfram Web Resource [last updated Nov 29, 2010]. Available from: http://mathworld.wolfram.com/ErrorPropagation.html.
20. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statist Med. 1996;15(4):361-87.
21. Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med. 1999;130:515-24.
22. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. New York: Springer; 2002.
23. Fritz AG, Ries LAG. The SEER Program Code Manual. Bethesda, MD: National Cancer Institute; 1998.
24. Havener L, Thornton M. Standards for Cancer Registries Volume II: Data Standards and Data Dictionary, 8th ed. Bethesda, MD: National Cancer Institute; 2003.
25. Bilimoria KY, Stewart AK, Tomlinson JS, et al. Impact of adjuvant radiation on survival: a note of caution when using cancer registry data to evaluate adjuvant treatments. Ann Surg Oncol. 2007;14(12):3321-7.